Management ChangeJun 16, 2026, 04:12 PM
Century Therapeutics CSO Chad Cowan Shifts to Part-Time Role
AI Summary
Century Therapeutics, Inc. entered into an Amended and Restated Employment Agreement with Chad Cowan, Ph.D., its Chief Scientific Officer. Under the new agreement, Dr. Cowan will continue in his role on a part-time basis. His annual salary will be reduced to $296,150, and he will be eligible for a pro-rated annual performance-based target bonus.
Key Highlights
- Chad Cowan, Ph.D., Chief Scientific Officer, will transition to a part-time role.
- Annual salary for Dr. Cowan will be reduced to $296,150.
- Dr. Cowan remains eligible for a pro-rated annual performance-based target bonus.
- Upon termination or resignation, Dr. Cowan is entitled to all accrued and unpaid base salary.
Price Impact
More from IPSC